457 related articles for article (PubMed ID: 25144163)
1. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
2. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
Zhu J; Fedewa S; Chen AY
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
[TBL] [Abstract][Full Text] [Related]
3. Improvements in survival and disparities for advanced-stage laryngeal cancer.
LeBlanc BJ; Shi R; Mehta V; Mills G; Ampil F; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):169-73. PubMed ID: 25429594
[TBL] [Abstract][Full Text] [Related]
4. Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx.
Elegbede AI; Rybicki LA; Adelstein DJ; Kaltenbach JA; Lorenz RR; Scharpf J; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1111-7. PubMed ID: 25950990
[TBL] [Abstract][Full Text] [Related]
5. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
6. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
Wolf GT; Bellile E; Eisbruch A; Urba S; Bradford CR; Peterson L; Prince ME; Teknos TN; Chepeha DB; Hogikyan ND; McLean SA; Moyer J; Taylor JMG; Worden FP
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):355-366. PubMed ID: 28152117
[TBL] [Abstract][Full Text] [Related]
7. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
8. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
9. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
Chen AY; Fedewa S; Zhu J
Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.
Ko HC; Harari PM; Chen S; Wieland AM; Yu M; Baschnagel AM; Kimple RJ; Witek ME
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1126-1133. PubMed ID: 29049434
[TBL] [Abstract][Full Text] [Related]
11. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
[TBL] [Abstract][Full Text] [Related]
12. Survival Outcomes in Early Stage Laryngeal Cancer.
Megwalu UC; Panossian H
Anticancer Res; 2016 Jun; 36(6):2903-7. PubMed ID: 27272804
[TBL] [Abstract][Full Text] [Related]
13. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
14. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
[TBL] [Abstract][Full Text] [Related]
15. Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.
Holliday MA; Tavaluc R; Zhuang T; Wang H; Davidson B
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):362-6. PubMed ID: 23599071
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients.
Shin JY; Truong MT
Laryngoscope; 2015 Jul; 125(7):1667-74. PubMed ID: 25694265
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
18. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
[TBL] [Abstract][Full Text] [Related]
19. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
20. Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.
Dutta R; Husain Q; Kam D; Dubal PM; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):54-9. PubMed ID: 25917664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
